Elevated Autophagy and Mitochondrial Dysfunction in the Smith-Lemli-Opitz Syndrome

Area of Science:

• Biochemistry
• Cell Biology
• Genetics

Background:

• Smith-Lemli-Opitz syndrome (SLOS) is an inherited metabolic disorder.
• It results from mutations in DHCR7, impairing cholesterol synthesis.
• Accumulation of 7-dehydrocholesterol (7DHC) is a key feature of SLOS.

Purpose of the Study:

• To investigate the role of autophagy in SLOS pathophysiology.
• To explore the link between 7DHC accumulation, oxidative stress, and mitochondrial function in SLOS.

Main Methods:

• Analysis of autophagy markers (LC3B-II, beclin-1) in SLOS fibroblasts.
• Measurement of cellular 7DHC levels.
• Assessment of mitochondrial function using JC-1 assay.
• Quantification of PINK1 levels.

Main Results:

• SLOS fibroblasts exhibit elevated basal levels of LC3B-II, beclin-1, and autophagosomes.
• Increased autophagy markers correlate directly with cellular 7DHC concentrations.
• Antioxidant treatment reduces elevated LC3B-II levels, suggesting oxidative stress involvement.
• SLOS cells display mitochondrial dysfunction and elevated PINK1 levels, indicating mitophagy activation.

Conclusions:

• 7DHC accumulation in SLOS triggers oxidative stress, leading to mitochondrial dysfunction.
• Increased autophagy, particularly mitophagy, appears to be a compensatory response to remove damaged mitochondria in SLOS.
• These findings highlight a novel mechanism in SLOS pathophysiology involving mitochondrial-autophagy crosstalk.